Literature DB >> 11251188

Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine.

B A Pelayo1, Y M Fu, G G Meadows.   

Abstract

We previously found that dietary tyrosine (Tyr) and phenylalanine (Phe) restriction significantly decreased the metastatic phenotype of the pigmented murine B16BL6 melanoma in vivo and decreased the in vitro invasion of these cells. Here we report that invasion and chemoinvasion through GFR Matrigel of the human amelanotic A375 melanoma also is significantly inhibited by Tyr and Phe deprivation in vitro. Deprivation of these two amino acids decreased the secretion and protein expression of tissue-type plasminogen activator (tPA) while expression and secretion of plasminogen activator inhibitor (PAI-1 and PAI-2) were increased. Moreover, nuclear extracts of Tyr- and Phe-deprived cells exhibited increased binding of the transcription factors, activator protein-1 (AP-1) and specific promoter-1 (Sp1), to consensus oligonucleotides as determined by electrophoretic mobility shift assay. Nuclear binding activity to the oligonucleotide consensus sequence for AP-1 was inhibited by antibody against c-Fos and more effectively inhibited by an antibody against c-Jun. We conclude that decreased invasion and chemoinvasion of A375 melanoma cells deprived of Tyr and Phe are related to decreased secretion of tPA and increased secretion of PAIs. Increased AP-1 and Sp1 binding implicates these transcription factors in the regulation of PAI expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251188     DOI: 10.3892/ijo.18.4.877

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling.

Authors:  Ya-Min Fu; Hui Zhang; Mingjie Ding; Yi-Qi Li; Xing Fu; Zu-Xi Yu; Gary G Meadows
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.

Authors:  Ya-Min Fu; Zu-Xi Yu; Huimin Lin; Xing Fu; Gary G Meadows
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

Review 3.  Enzymes in Metabolic Anticancer Therapy.

Authors:  Maristella Maggi; Claudia Scotti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells.

Authors:  Yurie Tonoike; Kazuyuki Matsushita; Takeshi Tomonaga; Koji Katada; Nobuko Tanaka; Hideaki Shimada; Yukio Nakatani; Yoshitaka Okamoto; Fumio Nomura
Journal:  BMC Cell Biol       Date:  2011-09-27       Impact factor: 4.241

Review 5.  Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis.

Authors:  Ana Hipólito; Filipa Martins; Cindy Mendes; Filipa Lopes-Coelho; Jacinta Serpa
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

6.  Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs.

Authors:  Maria Malvina Tsamouri; Blythe P Durbin-Johnson; William T N Culp; Carrie A Palm; Mamta Parikh; Michael S Kent; Paramita M Ghosh
Journal:  Metabolites       Date:  2022-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.